Intelnovation Group has donated two million baht in research funds to the Chulalongkorn Cancer Immunotherapy Fund and the Vaccine Research Center of the Faculty of Medicine at Chulalongkorn University to accelerate Covid-19 vaccine development. The funding also supports capable researchers working on the new vaccine and building up the country’s capacity to manufacture safe and efficacious vaccines for the masses.

Professor Suttipong Wacharasindhu, MD, dean of the Faculty of Medicine, receives the funds from Intelnovation senior executives on behalf of the Chulalongkorn Cancer Immunotherapy Fund and the Vaccine Research Center.